These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6300237)

  • 1. Suppression of humoral immunity in chickens prevents transient paralysis caused by a herpesvirus.
    Parker MA; Schierman LW
    J Immunol; 1983 May; 130(5):2000-1. PubMed ID: 6300237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclophosphamide-induced amelioration of Marek's disease in Marek's disease-susceptible chickens.
    Lu YS; Kermani-Arab V; Moll T
    Am J Vet Res; 1976 Jun; 37(6):687-92. PubMed ID: 180852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of Marek's disease virus strain AC-1 on cellular immunity in birds carrying endogenous viral genes.
    Lessard M; Hutchings DL; Spencer JL; Lillehoj HS; Gavora JS
    Avian Dis; 1996; 40(3):645-53. PubMed ID: 8883796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional analysis of host responses to Marek's disease virus infection in genetically resistant and susceptible chickens.
    Sarson AJ; Parvizi P; Lepp D; Quinton M; Sharif S
    Anim Genet; 2008 Jun; 39(3):232-40. PubMed ID: 18371127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenicity of low-virulence Marek's disease viruses in normal versus immunologically compromised chickens.
    Calnek BW; Fabricant J; Schat KA; Murthy KK
    Avian Dis; 1977; 21(3):346-58. PubMed ID: 199152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An acute form of transient paralysis induced by highly virulent strains of Marek's disease virus.
    Witter RL; Gimeno IM; Reed WM; Bacon LD
    Avian Dis; 1999; 43(4):704-20. PubMed ID: 10611987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of host-pathogen interactions to identify sustainable vaccine strategies to Marek's disease.
    Baaten BJ; Butter C; Davison TF
    Vet Immunol Immunopathol; 2004 Aug; 100(3-4):165-77. PubMed ID: 15207454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between the immunosuppressive potential and the pathotype of Marek's disease virus isolates.
    Calnek BW; Harris RW; Buscaglia C; Schat KA; Lucio B
    Avian Dis; 1998; 42(1):124-32. PubMed ID: 9533089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Very virulent plus strains of MDV induce an acute form of transient paralysis in both susceptible and resistant chicken lines.
    Xu M; Fitzgerald SD; Zhang H; Karcher DM; Heidari M
    Viral Immunol; 2012 Aug; 25(4):306-23. PubMed ID: 22803780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four distinct neurologic syndromes in Marek's disease: effect of viral strain and pathotype.
    Gimeno IM; Witter RL; Reed WM
    Avian Dis; 1999; 43(4):721-37. PubMed ID: 10611988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired host resistance against local JMV Marek's disease tumors after thymectomy and after bursectomy.
    Lam KM; Linna TJ
    Adv Exp Med Biol; 1982; 149():679-85. PubMed ID: 6293284
    [No Abstract]   [Full Text] [Related]  

  • 12. Abundance of IFN-alpha and IFN-gamma mRNA in blood of resistant and susceptible chickens infected with Marek's disease virus (MDV) or vaccinated with turkey herpesvirus; and MDV inhibition of subsequent induction of IFN gene transcription.
    Quéré P; Rivas C; Ester K; Novak R; Ragland WL
    Arch Virol; 2005 Mar; 150(3):507-19. PubMed ID: 15592893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplantable Marek's disease lymphomas. III. Induction of MHC-restricted tumor immunity by lymphoblastoid cells in F1 hosts.
    DiFronzo NL; Schierman LW
    Int J Cancer; 1989 Sep; 44(3):474-6. PubMed ID: 2550373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syngeneic Marek's disease virus (MDV)-specific cell-mediated immune responses against immediate early, late, and unique MDV proteins.
    Omar AR; Schat KA
    Virology; 1996 Aug; 222(1):87-99. PubMed ID: 8806490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marek's disease virus-induced transient paralysis is associated with cytokine gene expression in the nervous system.
    Abdul-Careem MF; Hunter BD; Sarson AJ; Mayameei A; Zhou H; Sharif S
    Viral Immunol; 2006; 19(2):167-76. PubMed ID: 16817759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-mediated immunity in Marek's disease: cytotoxic responses in resistant and susceptible chickens and relation to disease.
    Confer AW; Adldinger HK
    Am J Vet Res; 1980 Mar; 41(3):307-12. PubMed ID: 6445171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of B-haplotype on the relative efficacy of Marek's disease vaccines of different serotypes.
    Bacon LD; Witter RL
    Avian Dis; 1993; 37(1):53-9. PubMed ID: 8383961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marek's disease virus-induced expression of cytokine genes in feathers of genetically defined chickens.
    Abdul-Careem MF; Read LR; Parvizi P; Thanthrige-Don N; Sharif S
    Dev Comp Immunol; 2009 Apr; 33(4):618-23. PubMed ID: 19041890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of B-cell immunosuppression on age-related resistance of chickens to Marek's disease.
    Sharma JM; Witter RL
    Cancer Res; 1975 Mar; 35(3):711-7. PubMed ID: 234791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of serotype 2 and 3 Marek's disease vaccines on the development of avian leukosis virus-induced pre-neoplastic bursal follicles.
    Marsh JD; Bacon LD; Fadly AM
    Avian Dis; 1995; 39(4):743-51. PubMed ID: 8719208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.